MIRA Pharmaceuticals, Inc. Share Price
MIRAMIRA Pharmaceuticals, Inc. Stock Performance
Open $1.43 | Prev. Close $1.47 | Circuit Range N/A |
Day Range $1.43 - $1.47 | Year Range $0.73 - $2.44 | Volume 1,214 |
Average Traded $1.45 |
MIRA Pharmaceuticals, Inc. Share Price Chart
About MIRA Pharmaceuticals, Inc.
MIRA Pharmaceuticals, Inc. operates as a pre-clinical-stage pharmaceutical development company with two neuroscience programs targeting a range of neurologic and neuropsychiatric disorders. The company holds exclusive U.S., Canadian, and Mexican rights for Ketamir-2, a patent pending oral ketamine analog under investigation to deliver ultra-rapid antidepressant effects for individuals battling treatment-resistant depression, major depressive disorder with suicidal ideation, and post-traumatic stress disorder. In addition, its oral pharmaceutical marijuana, MIRA-55, is under investigation for treating adult patients suffering from anxiety and cognitive decline, often associated with early-stage dementia. The company was formerly known as MIRA1a Therapeutics, Inc. MIRA Pharmaceuticals, Inc. was incorporated in 2020 and is based in Miami, Florida.
MIRA Pharmaceuticals, Inc. Historical Data
| Day | Open | Close | Change % |
|---|---|---|---|
16-Jan-26 | $1.47 | $1.47 | +0.68% |
15-Jan-26 | $1.46 | $1.46 | -2.01% |
14-Jan-26 | $1.47 | $1.49 | +1.71% |
13-Jan-26 | $1.48 | $1.47 | -1.01% |
12-Jan-26 | $1.48 | $1.48 | -0.67% |
09-Jan-26 | $1.50 | $1.49 | +1.36% |
08-Jan-26 | $1.47 | $1.47 | -1.34% |